Racotek Extends Mobile Data Product Line To Embrace Industry Standards.MINNEAPOLIS--(BUSINESS WIRE)--May 5, 1997-- New Products Announced in Conjunction with Third Annual User Symposium Racotek Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : RACO RACO Royal Australian College of Ophthalmologists RACO Rear Area Combat Operations RACO Rand Athletic Club Orienteers (South Africa) RACO Remote Alarms and Controls ), a mobile data communication software and services company, today announced at its Third Annual User Symposium five new products and services for rapid and effective deployment of mobile data solutions. The products extend existing industry standards to the wireless environment. With these introductions Racotek leads the wireless industry in creating easier, more reliable, and effective wireless data solutions for customers and end users. Additions to KeyWare(TM), Racotek's wireless distributed computing (1) The use of multiple computers networked throughout a wide geographical area, or the world via the Internet, in order to solve a single problem. See grid computing. (2) The use of multiple computers in an enterprise rather than one centralized system. software, and services include: WebAnyWhere, a KeyWare-based agent enabling intranet applications to communicate wirelessly; KeyWare/MAPI/Exchange Agent, enabling MAPI-compliant or Exchange-enabled applications to communicate wirelessly; KeyWare for Windows CE (Windows Consumer Electronics) Microsoft's version of Windows for handheld devices and embedded systems that use x86, ARM, MIPS and SHx CPUs. Windows CE .NET superseded Windows CE 3.0. , supporting the Windows CE operating system operating system (OS) Software that controls the operation of a computer, directs the input and output of data, keeps track of files, and controls the processing of computer programs. on the KeyWare portable server; and Wireless Computing Service, a service which enables complete outsourcing of a wireless computing solution. Racotek also announced its WinSock 2 based product, a platform for wireless data communicatioged us to embrace standards for wireless compuilable. The products and services announced todless environment. The product is opti mized for intranet-based applications requiring access to central corpere will be made available in July, 1997. power of these products is that customers who are already using KeyWare to support vertical applications of mobile data, can easily extend desktop features such as e-mail and scheduling to their wireless workforce. Those wireless workers are seamlessly integrated with the LAN-bas products are being extended to the Windows CE o this platform as customers needs demand. This product will be available in July, 1997. IT outsourcing continues to grow rapidly, as it allows customers to s and a single monthly fee, customers can, via an Internet connection to Racotek, obtain a fully functional wireless computing solution for their mobile workforce. The solution can include purchase or lease of all the required components: portable computers, wireless modems A modem and antenna that transmits and receives over the air. Wireless modems support several technologies, including 802.11, Bluetooth, CDPD, DataTAC, Mobitex and Ricochet. There are wireless modems for laptops, handhelds and cellphones. , and software. Wireless Computing Service customers have full 7 x 24 support available from Racotek's Managed Network Services. The service will be available in June. Pricing is dependent upon volume and selected components. Racotek's new WinSock 2 based product complies with the Narrowband Socket (NBS (National Bureau of Standards) See NIST. NBS - National Bureau of Standards: part of the US Department of Commerce, now NIST. ) specification developed by Nokia and Intel. "WinSock 2 is the first industry standard to provide applications an interface to multiple transport protocols, and tthe WinSock 2 API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol. and defines requirements for reliable and efficient wireless data communication. The first components of Racotek's WinSock 2 based solution, fully c support, will be available in the third quarof contact for customers using multi-vendor en or Walt & Company NS PRODUCT REPEATS: New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of 212-752-9600 o with Hyperlinks to y1997 financial results Business Editors THE WOODLANDS, Texas--(BUSINESS WIRE)--May 5, 1997--GENEMEDICINE Inc. (NASDAQ: GMED) today reported a net loss of $n revenues was attributable to increased contract revenue and increased research and development grant revens and short-term investments of $31,817,083. Based on its current plans, the Company believes that its available cash, including committed funding from corporate partners and proceeds from projected interest income, will be sufficient to meet the Company's operating expenses Operating expenses The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted. and capital requirements Capital requirements Financing required for the operation of a business, composed of long-term and working capital plus fixed assets. into the second half of 1999. The initial business focus of Gene Medicine is the development of gene medicines for treating certain cancers, musculoskeletal disorders Musculoskeletal disorders (MSDs) can affect the body's muscles, joints, tendons, ligaments and nerves. Most-work related MSDs develop over time and are caused either by the work itself or by the employees' working environment. , and pulmonary diseases as well as in development of nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. vaccines for the prophylactic treatment prophylactic treatment n. The institution of measures to protect a person from a disease to which he or she has been, or may be, exposed. Also called preventive treatment. of viral and bacterial infections. The Company intends to develop and commercialize its products through corporate alliances with major biotechnology and pharmaceutical companies. As previously reported, the Company has received clearance from the U.S. Food & Drug Administration to cd pharmaceutical products that are designed to lymer-based systems, each able to be applied to specific clinical targets. Gene Medicines also incorporate novel DNA sequences DNA sequence Genetics The precise order of bases–A,T,G,C–in a segment of DNA, gene, chromosome, or an entire genome. See Base pair, Base sequence analysis, Chromosome, Gene, Genome. that may be used to control the tissue-specificity, duration and level of functioning of administered genesnd scaleable integrated manufacturing processend gene expression technologies, the manufacture statements. Actua l results may differ materially. Factors that could cause or contribute to differences include continued scientific progress in its research and development programs, the scope and results pf preclinical testing Noun 1. preclinical test - a laboratory test of a new drug or a new invasive medical device on animal subjects; conducted to gather evidence justifying a clinical trial preclinical phase, preclinical trial and clinical trials, the time and costs involved in obtaining regulatory approvals, the costs involved in filin31, 1996.
GENEMEDICINE INC.
(A Delaware Corporation in the Development Stage)
Statements of Opera (unaudited)
Revenues:
income 430,946 491,461
_______________________
2,170,946 1,572,461
Expenses:
Research and development 3,279,329 3,561,661
Condensed Balanced Sheets
____________
(unaudited)
Assets
______
Cash, cash equivalents and
short-term investments $ 31,817,083 $ 30,872,006
Prepaid expenses and other ________
Equipment, furniture and
leasehold improvements, net 3,464,189 2,998,416
Deposits and other assets 8,395 8,395
__________ urrent liabilities $
1,571,748 $ 1
,940,638
Long-term liabilities 2,380,339 2,179,363
Stockholder's equity
CONTACT: GENEMEDICINE Inc., The Woodlands
Pamela M. Murphy, 281/364-1150
KEYWORD: TEXAS
INDUSTRY KEYWORD: BIOTECHNOLGY MEDICINE PHARMACEUTICAL EARNINGS
URL: http://www.gmed.com
REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or
800-225-2030; SF 415-986-4422 or 800-227-0845; LA 310-820-9473
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion